[1] |
VERMEULEN MA, SLAETS L, CARDOSO F, et al.Pathological characterisation of male breast cancer:results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program[J].Eur J Cancer, 2017, 57:S13. |
[2] |
NDOM P, UM G, BELL EM, et al.A meta-analysis of male breast cancer in Africa[J].Breast, 2012, 21(3):237. doi: 10.1016/j.breast.2012.01.004 |
[3] |
KORDE LA, ZUJEWSKI JA, KAMIN L, et al.Multidisciplinary meeting on male breast cancer:summary and research recommendations[J].J Clin Oncol, 2010, 28(12):2114. doi: 10.1200/JCO.2009.25.5729 |
[4] |
ANDERSON WF, JATOI I, TSE J, et al.Male breast cancer:a population-based comparison with female breast cancer[J].J Clin Oncol, 2010, 28(2):232. doi: 10.1200/JCO.2009.23.8162 |
[5] |
DOYLE S, STEEL J, PORTER G.Imaging male breast cancer[J].Clin Radiol, 2011, 66(11):1079. doi: 10.1016/j.crad.2011.05.004 |
[6] |
ZAGOURI F, SERGENTANIS TN, CHRYSIKOS D, et al.Fulvestrant and male breast cancer:a pooled analysis[J].Breast Cancer Res Treat, 2015, 149(1):269. doi: 10.1007/s10549-014-3240-z |
[7] |
DIETZ JR, PARTRIDGE AH, GEMIGNANI ML, et al.Breast cancer management updates:young and older, pregnant, or male[J].Ann Surg Oncol, 2015, 22(10):3219. doi: 10.1245/s10434-015-4755-1 |
[8] |
CONTRACTOR KB, KAUR K, RODRIGUES GS, et al.Male breast cancer:is the scenario changing[J].World J Surg Oncol, 2008, 6(1):58. doi: 10.1186/1477-7819-6-58 |
[9] |
WOLFF AC, HAMMOND MEH, SCHWARTZ JN, et al.Guideline summary:American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for human epidermal growth factor receptor HER2 testing in breast cancer[J].J Oncol Pract, 2007, 3(1):48. doi: 10.1200/JOP.0718501 |
[10] |
PINTO R, PILATO B, OTTINI L, et al.Different methylation and microRNA expression pattern in male and female familial breast cancer[J].J Cell Physiol, 2013, 228(6):1264. doi: 10.1002/jcp.v228.6 |
[11] |
LEHMANN U, STREICHERT T, OTTO B, et al.Identification of differentially expressed microRNAs in human male breast cancer[J].BMC Cancer, 2010, 10(1):109. doi: 10.1186/1471-2407-10-109 |
[12] |
RUGO HS, RUMBLE RB, MACRAE E, et al.Endocrine therapy for hormone receptor-positive metastatic breast cancer:American Society of Clinical Oncology Guideline[J].J Clin Oncol, 2016, 34(25):3069. doi: 10.1200/JCO.2016.67.1487 |
[13] |
LORDACHE I, UNC O, LILIANA S, et al.Male breast cancer-actuality of our days[J].Ars Medica Tomitana, 2015, 20(3):159. doi: 10.2478/arsm-2014-0029 |